Senior Director Corporate Development in San Francisco, CA resume.doc

Assaf Guterman, CFA _______________________________________________________________ Tel: 408-931-3156 E-mail: [email protected] _______________________________________________________________ Dynamic, results oriented and experienced corporate development and financial professional with over 12 years of experience in the healthcare sector. Led and executed a variety of strategic and financial transactions in both public and private multi-national pharmaceutical companies. Executed and advised on a variety of M&A, licensing and other strategic initiatives in the pharma, med-tech and diagnostics industries at various capacities (in-house corporate development, investment banking advisory and equity-research coverage).

Work Experience: 2012 - Present

Oberon Securities, Investment Banking, Life Sciences; Managing Director  Provide M&A and strategic advisory services. (Outlining objectives and establishing criteria, exploring and identifying possible candidates, advising on valuation and structuring opportunities, screening term sheets, spearheading due diligence, negotiation and definitive agreements drafting).  Manage the fund raising process for both private and public companies. (Help the client determining the appropriate amount, financing type and use of capital, preparing marketing materials, including the business plan and investor presentation, identifying relevant investor base, marketing to a selected network of capital sources, evaluating investment proposals, coordinating due diligence, negotiating final terms of the financing).  Construct comprehensive and granular financial models, valuation metrics and profitability analysis, such as NPV, IRR, sensitivity analysis, etc.,  Maintain a wide network of relationships in the U.S. and Israeli pharmaceutical and med-tech industries.  Enjoy a wide network of institutional investors (Asset Managers, Hedge Funds, Private Equity, VCs), high net worth individuals and strategic players in the healthcare sector.

2010 - 2012

Dexcel Pharma, Director, Corporate Development  Built and managed the company’s corporate/business development team.  Lead a cross functional team, which developed the company’s strategic plan.  Established the company’s mid to long-term strategy, evaluated the strategy based on pre-determined metrics and tracked the progress made toward reaching the desired targets.  Co-chaired the strategic committee, analyzing organic and non-organic growth drivers.  Presented the recommended action items to senior management.  Screened and negotiated for product in-licensing targets.  Built and maintained an up-to-date competitive landscape analysis of the generics pharmaceutical market.  Provided in-house M&A advisory services, supporting the company’s non-organic growth initiatives.  Supported the company’s cross-border expansion strategy through target identification and managing the acquisition process.  Spearheaded the integration process of new products and business units.

2007 - 2009

Lazard Capital Market, Senior Equity Research Analyst; Medical Devices  Published reports and advised sales force and buy-side clients on names under coverage.  Arranged non-deal roadshows and management meetings for our buy-side clients,  Hosted events with companies’ managements and thought leading physicians.  Published periodic industry reports, following trends in variety of segments within the healthcare industry.  Worked closely with Sales and Trading in order to monetize our products and maximize trading volumes.  Coverage included variety of companies from the Cardiology, Neurology, Diagnostics, General and minimal invasive surgery, Orthopedics and Aesthetics sectors.  Vetted and analyzed companies for M&A and other strategic transactions.

2006 - 2007

Lazard Capital Market, Equity Research Analyst; Medical Devices  Attended medical meetings, industry conferences, analysts days and FDA panel meetings to obtain intelligence on new products and market trends, as well as to establish industry contacts.  Conducted proprietary channel checks, including physician calls and industry surveys.  Constructed granular financial models for all companies under coverage and prospective banking deals.

2004-2006

Taro Pharmaceuticals LTD, Director, Finance Developed and maintained the company’s strategic plan and financial projections.

Supervised a group of financial analysts that performed ongoing analysis of the company’s financial and operational performance. Supported the company’s non-organic growth initiatives from contributing to establishing the strategy, through transaction execution, all the way to new product/business integration.  Prepared and maintained a comparative analysis of the generic pharmaceuticals industry.  Negotiated sales terms with the wholesalers and large chains.  Responsible for Taro’s inter-company transfer pricing methodology and implementation.  Prepared the annual corporate budget, and monitored the actual performance against that budget along the year.  Managed the debt and equity structure of the company, including negotiation and execution of various public and private offerings and the ongoing interaction with the commercial and investment banks, institutional investors and the rating agencies. 2002-2003

Taro Pharmaceuticals LTD, Senior Financial Analyst  Co-managed the preparation of the quarterly financial reports and the annual SEC reporting, including financial consolidation, supporting schedules and footnotes to the company’s financial statements, in accordance with US GAAP.  Helped maintaining the company’s relations with Wall Street, and participated in “telling the company’ story” to the investment community.  Managed the company’s cash portfolio (in excess of 100 Million Dollars), as well as its currency an interest rate hedging strategy.  Negotiated the company’s insurance policies and oversaw the company’s overall risk portfolio.  Co-managed Sarbanes-Oxley internal control compliance work.

2000 - 2002

Government of Israel Mission to New York, Economist  Coordinated financial strategies of the Israel government in global markets.  Worked directly with U.S. investment banks on debt issuances and activities monitoring in secondary markets.  Analyzed the feasibility and expenses of the Israel Bonds Organization, and the government’s positions in the financial markets.  Updated international rating agencies and institutional investors, and present Israel’s economic and political developments.  Editor of the “Shekel,” a quarterly newsletter and a monthly update of macroeconomic and financial trends in Israel. Wrote commentary on Israel’s economic and financial markets.  Chaired the Economic Committee, responsible for RFP issuances and for the selection of fiscal agents for the Israel Government.  Responsible for dissemination of quarterly reports on the U.S. economy, financial markets and the Israel Bonds Organization to Israel’s Ministry of Finance.

1998 - 1999

Israel Ministry of Foreign Affairs, Security Field Officer,  In charge of physical and informational security at Israeli embassies and consulates around the world, including Madrid, Guatemala City, Toronto, Hong Kong and New York.  Supervised the implementation of emergency procedures.

1996 - 1997

Israel Ministry of Defense, Analyst  Managed and directed 12 agents.  Developed and implemented comprehensive training programs for new agents.

Education: 

Master of Business Administration (MBA) in Finance Zicklin Business School, Baruch College. New York, NY



Bachelor of Arts (BA) in Political Science Tel Aviv University, Tel Aviv, Israel.

Certifications:  

Chartered Financial Analyst (CFA) Licensed in NASD series 7, 63, 87

Additional Information:  

Fluent in English and Hebrew. Well versed in Microsoft Office applications, FactSet, Bloomberg, Reuters and First Call